BNF for Children March 2024 Update

This update contains 4 significant changes, 1 new monograph and 1 deleted monograph.

Significant Changes:

• Aripiprazole (Abilify® and generic brands): risk of pathological gambling [MHRA/CHM advice].
• Quinolones: must now only be prescribed when other commonly recommended antibiotics are inappropriate [MHRA/CHM advice] (see example in ciprofloxacin).
• Type 2 diabetes: updated guidance for management.
• Vitamin B₁₂: advise patients with known cobalt allergy to be vigilant for sensitivity reactions [MHRA/CHM advice] (advice in cyanocobalamin, hydroxocobalamin; see example in hydroxocobalamin).

New Monographs:

• Litfulo® [ritlecitinib].
• Livmarli® [maralixibat].

Deleted Monographs: Cinchocaine hydrochloride with fluocortolone caproate and fluocortolone pivalate.